Follow
Gennaro Pagano
Gennaro Pagano
Expert Medical Director & Group Leader in Early Development @ Roche
Verified email at roche.com
Title
Cited by
Cited by
Year
Age at onset and Parkinson disease phenotype
G Pagano, N Ferrara, DJ Brooks, N Pavese
Neurology 86 (15), 1400-1407, 2016
3562016
Calcium release channel RyR2 regulates insulin release and glucose homeostasis
G Santulli, G Pagano, C Sardu, W Xie, S Reiken, SL D’ascia, M Cannone, ...
The Journal of clinical investigation 125 (5), 1968-1978, 2015
2462015
Diabetes mellitus and Parkinson disease
G Pagano, S Polychronis, H Wilson, B Giordano, N Ferrara, F Niccolini, ...
Neurology 90 (19), e1654-e1662, 2018
2052018
Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease
Z Qamhawi, D Towey, B Shah, G Pagano, J Seibyl, K Marek, ...
Brain 138 (10), 2964-2973, 2015
2052015
Imaging in Parkinson’s disease
G Pagano, F Niccolini, M Politis
Clinical Medicine 16 (4), 371, 2016
2032016
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease
J Schulz, G Pagano, JA Fernández Bonfante, H Wilson, M Politis
Brain 141 (5), 1501-1516, 2018
1752018
β-adrenergic receptor responsiveness in aging heart and clinical implications
N Ferrara, K Komici, G Corbi, G Pagano, G Furgi, C Rengo, ...
Frontiers in physiology 4, 65481, 2014
1682014
Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis
G Pasqualetti, G Pagano, G Rengo, N Ferrara, F Monzani
The Journal of Clinical Endocrinology & Metabolism 100 (11), 4240-4248, 2015
1662015
Trial of prasinezumab in early-stage Parkinson’s disease
G Pagano, KI Taylor, J Anzures-Cabrera, M Marchesi, T Simuni, K Marek, ...
New England Journal of Medicine 387 (5), 421-432, 2022
1652022
Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis
G Savarese, F Musella, C D’Amore, E Vassallo, T Losco, F Gambardella, ...
JACC: heart failure 2 (2), 148-158, 2014
1652014
Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
A Chandra, PE Valkimadi, G Pagano, O Cousins, G Dervenoulas, ...
Human brain mapping 40 (18), 5424-5442, 2019
1512019
Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
G Pagano, G Rengo, G Pasqualetti, GD Femminella, F Monzani, ...
Journal of Neurology, Neurosurgery & Psychiatry 86 (7), 767-773, 2015
1402015
Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature
GD Femminella, G Rengo, K Komici, P Iacotucci, L Petraglia, G Pagano, ...
Journal of Alzheimer's Disease 42 (2), 369-377, 2014
1362014
REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease
G Pagano, R De Micco, T Yousaf, H Wilson, A Chandra, M Politis
Neurology 91 (10), e894-e905, 2018
1222018
Cholinergic imaging in dementia spectrum disorders
R Roy, F Niccolini, G Pagano, M Politis
European journal of nuclear medicine and molecular imaging 43, 1376-1386, 2016
1022016
Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure
V Parisi, G Rengo, P Perrone-Filardi, G Pagano, GD Femminella, ...
Circulation research 118 (8), 1244-1253, 2016
942016
Impact of Diabetes on Cardiac Sympathetic Innervation in Patients With Heart Failure: A 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study
S Paolillo, G Rengo, G Pagano, T Pellegrino, G Savarese, ...
Diabetes care 36 (8), 2395-2401, 2013
912013
Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studies
G Pagano, F Niccolini, P Fusar‐Poli, M Politis
Annals of neurology 81 (2), 171-180, 2017
882017
Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α2-adrenoceptor-catecholamine production axis in heart failure
G Rengo, A Lymperopoulos, C Zincarelli, GD Femminella, D Liccardo, ...
British journal of pharmacology 166 (8), 2430-2439, 2012
882012
β1-Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and …
A Cannavo, G Rengo, D Liccardo, G Pagano, C Zincarelli, MC De Angelis, ...
Circulation 128 (15), 1612-1622, 2013
832013
The system can't perform the operation now. Try again later.
Articles 1–20